Vr Adviser, LLC A Tyr Pharma Inc Transaction History

Vr Adviser, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.88 - $2.5 $2.2 Million - $2.93 Million	-1,171,436 Closed	0 $0
Q4 2022 May 15, 2023	SELL	$2.02 - $2.49 $459,455 - $566,357	-227,453 Reduced 16.26%	1,171,436 $2.57 Million
Q4 2022 Feb 14, 2023	SELL	$2.02 - $2.49 $19.2 Million - $23.7 Million	-9,527,453 Reduced 89.05%	1,171,436 $2.57 Million
Q3 2022 Nov 14, 2022	BUY	$2.79 - $4.15 $25.9 Million - $38.6 Million	9,300,000 Added 664.81%	10,698,889 $36.7 Million
Q2 2022 May 15, 2023	BUY	$2.63 - $5.61 $598,201 - $1.28 Million	227,453 Added 19.42%	1,398,889 $3.96 Million
Q1 2022 May 16, 2022	SELL	$4.75 - $7.54 $789,027 - $1.25 Million	-166,111 Reduced 10.61%	1,398,889 $7.48 Million
Q3 2021 Nov 15, 2021	BUY	$4.22 - $12.48 $6.6 Million - $19.5 Million	1,565,000 New	1,565,000 $14.2 Million

37.2M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.